Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from DaVita

$44 Million Bet On Occidental Petroleum? 3 Stocks Insiders are Buying

Although US stocks closed slightly lower on Monday, there were a few notable insider trades.

Supreme Court sides with insurer in dialysis coverage case - Roll Call

Supreme Court sides with insurer in dialysis coverage case - Roll Call

The Supreme Court decides in favor of an insurer in a case focused on reimbursement rates for kidney dialysis.

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

DaVita's Return on Invested Capital Overview

Pulled from Benzinga Pro data, DaVita (NYSE:DVA) posted Q1 earnings of $205.72 million, an increase from Q4 of 17.53%. Sales dropped to $2.82 billion, a 4.28% decrease between quarters.

The campaign behind California dialysis initiative files signatures for a place on the November ballot

Californians for Kidney Dialysis Patient Protection filed 692,521 raw signatures to place an initiative on the November ballot. The measure would enact staffing requirements, reporting requirements, ownership disclosure, and closing requirements for chronic dialysis clinics. The ballot initiative would also prohibit clinics from refusing to care for a patient based…

Recap: DaVita Q1 Earnings

DaVita (NYSE:DVA) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DaVita missed estimated earnings by 13.9%, reporting an EPS of $1.61 versus an estimate of $1.87.

DaVita: Q4 Earnings Insights

DaVita (NYSE:DVA) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DaVita beat estimated earnings by 12.22%, reporting an EPS of $2.02 versus an estimate of $1.8.

inkl

Read news from The Economist, FT, and more,
with one subscription

3 Warren Buffett Stocks to Buy in February: DaVita, Bristol Myers Squibb, and AbbVie

3 Warren Buffett Stocks to Buy in February: DaVita, Bristol Myers Squibb, and AbbVie

Warren Buffett’s value investing strategy has paid off, as its investment firm Berkshire Hathaway (BRK.A) has outperformed the broader market. Recently, the billionaire has become worther than Meta Platforms (FB) founder Mark Zuckerberg. Hence, we believe that the Berkshire Hathaway holdings AbbVie (ABBV), Bristol-Myers Squibb (BMY), and DaVita (DVA) might…

1 2 3

People

Mark Zuckerberg

Sonia Sotomayor

[ Brett M. ] Kavanaugh

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Berkshire Hathaway

Occidental Petroleum

Bristol Myers Squibb

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

406,903 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play